17 unchanged sentences
PERIOD TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID
−Removed: per share TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs MAXIMUM NUMBER OF SHARES
+Added: per share TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs MAXIMUM NUMBER (or Approximate DOLLAR VALUE) OF SHARES
that may yet be purchased
under the plans or programs
+Added: January 1 - January 31 4,029 $ 16.27 — 236,957,114
February 1 - February 28 9,034 16.56 — 236,957,114
−Removed: October 1 - October 31 93,965 17.16
−Removed: December 1 - December 31 383,016 18.14 — —
−Removed: Total 485,209 $ 17.92
−Removed: Authorization to Repurchase Common Stock
−Removed: During 2024, the Company repurchased shares of its common stock under repurchase authorizations as follows:
−Removed: PERIOD TOTAL NUMBER OF SHARES PURCHASED (1) (2)
−Removed: AVERAGE PRICE PAID per share TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs (2)
−Removed: MAXIMUM NUMBER (or Approximate DOLLAR VALUE) OF SHARES that may yet be purchased under the plans or programs (1)
−Removed: Prior Authorizations
+Added: March 1 - March 31 — — — 236,957,114
April 1 - April 30 18,877 15.83 — 236,957,114
5 unchanged sentences
October 1 - October 31 952 17.68 — 500,000,000
−Removed: October 29, 2024 Authorized Shares $ 300,000,000
November 1 - November 30 — — — 500,000,000
1 unchanged sentence
Total 234,496 $ 16.24
−Removed: 1 On May 31, 2023, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions.
−Removed: On April 30, 2024, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization.
−Removed: On October 29, 2024, the Company's Board of Directors authorized the repurchase of up to $300.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization.
+Added: Authorization to Repurchase Common Stock
+Added: On October 28, 2025, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock, superseding the previous $300.0 million stock repurchase authorization.
The stock repurchase authorization expires on October 27, 2026, and the Company may suspend or terminate repurchases at any time without prior notice.
−Removed: The Company is not obligated under this authorization to repurchase any specific number of shares.
−Removed: 2 Repurchases of common stock in April 2024 were made under the May 31, 2023 $500.0 million stock repurchase authorization.
−Removed: May 2024 through October 2024 were repurchased under the April 30, 2024 $500.0 million stock repurchase authorization.
−Removed: November and December 2024 repurchases were repurchased under the October 29, 2024 $300.0 million stock repurchase authorization.
−Removed: As of December 31, 2024, the Company was authorized to repurchase an additional $237.0 million of the Company's common stock.
+Added: Under the Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued.
+Added: As of December 31, 2025, the Company had $500.0 million remaining under its current share repurchase authorization.
+Added: Subsequent Activity
+Added: In January 2026, the Company repurchased 2.9 million shares of its common stock at an average price of $17.27 per share for a total of $50.0 million resulting in $450.0 million of authorized share repurchases remaining.
Stock Performance Graph
1 unchanged sentence
The comparison assumes $100 was invested on December 31, 2020, in the Company's common stock and in each of the indexes and assumes reinvestment of dividends, as applicable.
−Removed: The Company's data for periods prior to the closing of the Merger is the stock performance of Legacy HR.
+Added: The Company's data for periods prior to July 20, 2022, is the stock performance of Healthcare Realty Trust Incorporated (now known as HRTI, LLC) ("Legacy HR"), which merged into Healthcare Trust of America, Inc.
+Added: (now known as Healthcare Realty Trust Incorporated)(the "Merger").
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.